Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-20-014377
Filing Date
2020-06-08
Accepted
2020-06-08 15:26:57
Documents
81
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2019_bostontherapeutics.htm 10-K 1025175
2 CERTIFICATION f10k2019ex31-1_bostonthera.htm EX-31.1 12433
3 CERTIFICATION f10k2019ex31-2_bostonthera.htm EX-31.2 12684
4 CERTIFICATION f10k2019ex32-1_bostonthera.htm EX-32.1 5633
5 CERTIFICATION f10k2019ex32-2_bostonthera.htm EX-32.2 5428
  Complete submission text file 0001213900-20-014377.txt   5731762

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bthe-20191231.xml EX-101.INS 829204
7 XBRL SCHEMA FILE bthe-20191231.xsd EX-101.SCH 65359
8 XBRL CALCULATION FILE bthe-20191231_cal.xml EX-101.CAL 66494
9 XBRL DEFINITION FILE bthe-20191231_def.xml EX-101.DEF 335005
10 XBRL LABEL FILE bthe-20191231_lab.xml EX-101.LAB 529656
11 XBRL PRESENTATION FILE bthe-20191231_pre.xml EX-101.PRE 437737
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54586 | Film No.: 20949042
SIC: 2834 Pharmaceutical Preparations